AADAC Antikörper (AA 201-300)

Produktnummer ABIN513029

Es sind 5+ Publikationen für dieses Produkt verfügbar. Der Maus Monoklonal anti-AADAC Antikörper wird verwendet zum Nachweis von AADAC in Proben von Human. Er wurde validiert für WB und ELISA.

Kurzübersicht für AADAC Antikörper (AA 201-300) (ABIN513029)

Target: AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser AADAC Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Klon: 2E8

Produktdetails anti-AADAC Antikörper

Bindungsspezifität: AA 201-300

Verwendungszweck: Mouse monoclonal antibody raised against a partial recombinant AADAC.

Sequenz: QLLDDPDVKI KLKIQSLIYP ALQPLDVDLP SYQENSNFLF LSKSLMVRFW SEYFTTDRSL EKAMLSRQHV PVESSHLFKF INWSSLLPER FIKGHVYNNP

Kreuzreaktivität: Human

Produktmerkmale: Antibody Reactive Against Recombinant Protein.

Immunogen: AADAC (NP_001077, 201 a.a. ~ 300 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

Isotyp: IgG2b

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: In 1x PBS, pH 7.4

Handhabung: Aliquot to avoid repeated freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-AADAC Antikörper (ABIN513029)

Muta, Fukami, Nakajima, Yokoi: "N-Glycosylation during translation is essential for human arylacetamide deacetylase enzyme activity." in: Biochemical pharmacology, Vol. 87, Issue 2, pp. 352-9, (2014) (PubMed).

Kobayashi, Fukami, Nakajima, Watanabe, Nakajima, Yokoi: "Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse." in: Drug metabolism and disposition: the biological fate of chemicals, Vol. 40, Issue 4, pp. 671-9, (2012) (PubMed).

Shimizu, Fukami, Kobayashi, Takamiya, Aoki, Nakajima, Yokoi: "A novel polymorphic allele of human arylacetamide deacetylase leads to decreased enzyme activity." in: Drug metabolism and disposition: the biological fate of chemicals, Vol. 40, Issue 6, pp. 1183-90, (2012) (PubMed).

Kobayashi, Fukami, Higuchi, Nakajima, Yokoi: "Metabolic activation by human arylacetamide deacetylase, CYP2E1, and CYP1A2 causes phenacetin-induced methemoglobinemia." in: Biochemical pharmacology, Vol. 84, Issue 9, pp. 1196-206, (2012) (PubMed).

Watanabe, Fukami, Nakajima, Takamiya, Aoki, Yokoi: "Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis." in: Drug metabolism and disposition: the biological fate of chemicals, Vol. 37, Issue 7, pp. 1513-20, (2009) (PubMed).

Details zu AADAC

Target: AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))

Andere Bezeichnung: AADAC

Hintergrund: Full Gene Name: arylacetamide deacetylase (esterase)
Synonyms: CES5A1,DAC

Gen-ID: 13

NCBI Accession: NM_001086